3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerBlood-Borne Infections, Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, HIV infectious disease, Infections, Neoplasms by Site, RNA Virus Infections, Urogenital Diseases, anal margin squamous cell carcinoma, anal squamous cell carcinoma, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, immune system disorder, inborn error of immunity, infectious disease, intestinal disorder, lentivirus infection, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, squamous cell carcinoma of rectum, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 22026-10-05NCT04929028
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anal margin squamous cell carcinoma, anus basaloid carcinoma, anus disorder, anus neoplasm, cloacogenic carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasmActive, not recruitingPhase 32026-10-01NCT03233711
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anal canal squamous cell carcinoma, anal margin squamous cell carcinoma, anus basaloid carcinoma, anus disorder, anus neoplasm, cloacogenic carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasmActive, not recruitingPhase 22026-09-14NCT04166318